To test whether CFS gene expression is dependent on mitochondrial OXPHOS activity, we treated cells with sodium azide (NaN3) to inhibit mitochondrial respiration and observed decreased expression of all tested CFS genes in both control and FANCD2-depleted cells (Fig. 4b). This evidence concerns the gene FANCD2 and myalgic encephalomeyelitis/chronic fatigue syndrome.